Last reviewed · How we verify

NCT05921747

The Impact of Innovative Technology Strategies on Implementing Exercise Programs Using Fully Immersive Virtual Reality for Postpartum Women

Active, enrolled NA Last updated 13 April 2026
What this trial tests

NA trial testing Traditional exercise as control group in Post Partum Lumbopelvic Pain in 34 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
2 August 2023
Primary endpoint
31 March 2026
30 April 2026

Quick facts

Lead sponsorShalamar Institute of Health Sciences
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment34
Start date2 August 2023
Primary completion31 March 2026
Estimated completion30 April 2026
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Shalamar Institute of Health Sciences

Who can join

Adults 20 to 40, female only, with Post Partum Lumbopelvic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to determine the effect of traditional exercise through using fully immersive virtual reality in postpartum female with lumbopelvic pain. This study will be single-blind randomized clinical -trial and will be conducted at Shalamar Institute of health sciences in 1 year after the approval by institutional review board. Sixty female participants with a history of lumbopelvic pain will be recruited on the basis of inclusion and exclusion criteria. Data will be collected after taking written Informed Consent from each patient. The included participants will be randomized by gold fish randomization method and allocated to two groups (A \& B) each with 30 participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Shalamar Institute of Health Sciences trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05921747.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing